Oikawa Y - Search Results

1

Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.

Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T; consultation of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Baden MY, et al. Among authors: oikawa y. Diabetol Int. 2018 Jul 3;10(1):58-66. doi: 10.1007/s13340-018-0362-2. eCollection 2019 Jan. Diabetol Int. 2018. PMID: 30800564 Free PMC article.

2

T-cell function in anti-GAD65(+)diabetes with residual beta-cell function.

Suzuki R, Shimada A, Maruyama T, Funae O, Morimoto J, Kodama K, Oikawa Y, Kasuga A, Matsubara K, Saruta T, Narumi S. Suzuki R, et al. Among authors: oikawa y. J Autoimmun. 2003 Feb;20(1):83-90. doi: 10.1016/s0896-8411(02)00093-8. J Autoimmun. 2003. PMID: 12604315

3

Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system.

Yamada S, Irie J, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Saruta T. Yamada S, et al. Among authors: oikawa y. Autoimmunity. 2003 Mar;36(2):63-70. doi: 10.1080/0891693031000079266. Autoimmunity. 2003. PMID: 12820687

4

Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice.

Oikawa Y, Shimada A, Kasuga A, Morimoto J, Osaki T, Tahara H, Miyazaki T, Tashiro F, Yamato E, Miyazaki J, Saruta T. Oikawa Y, et al. J Immunol. 2003 Dec 1;171(11):5865-75. doi: 10.4049/jimmunol.171.11.5865. J Immunol. 2003. PMID: 14634096

5

Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer system.

Yamada S, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Irie J, Saruta T. Yamada S, et al. Among authors: oikawa y. Ann N Y Acad Sci. 2003 Nov;1005:211-4. doi: 10.1196/annals.1288.028. Ann N Y Acad Sci. 2003. PMID: 14679061

6

NKT cell frequency in Japanese type 1 diabetes.

Oikawa Y, Shimada A, Yamada S, Motohashi Y, Nakagawa Y, Irie J, Maruyama T, Saruta T. Oikawa Y, et al. Ann N Y Acad Sci. 2003 Nov;1005:230-2. doi: 10.1196/annals.1288.033. Ann N Y Acad Sci. 2003. PMID: 14679066

7

Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity.

Nakagawa Y, Shimada A, Oikawa Y, Irie J, Shigihara T, Tsumura K, Narumi S, Saruta T. Nakagawa Y, et al. Among authors: oikawa y. Ann N Y Acad Sci. 2003 Nov;1005:359-61. doi: 10.1196/annals.1288.059. Ann N Y Acad Sci. 2003. PMID: 14679092

8

N-acetyl-cysteine accelerates transfer of diabetes into non-obese diabetic scid mice.

Irie J, Shimada A, Oikawa Y, Shigihara T, Saruta T. Irie J, et al. Among authors: oikawa y. Diabetologia. 2004 Oct;47(10):1803-9. doi: 10.1007/s00125-004-1529-x. Epub 2004 Oct 22. Diabetologia. 2004. PMID: 15502923

9

CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis.

Morimoto J, Yoneyama H, Shimada A, Shigihara T, Yamada S, Oikawa Y, Matsushima K, Saruta T, Narumi S. Morimoto J, et al. Among authors: oikawa y. J Immunol. 2004 Dec 1;173(11):7017-24. doi: 10.4049/jimmunol.173.11.7017. J Immunol. 2004. PMID: 15557199

10

Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD mice.

Kodama K, Shimada A, Funae O, Morimoto J, Irie J, Shigihara T, Oikawa Y, Tokui M, Watanabe K, Saruta T. Kodama K, et al. Among authors: oikawa y. Autoimmunity. 2004 Sep-Nov;37(6-7):481-7. doi: 10.1080/08916930400001909. Autoimmunity. 2004. PMID: 15621575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

539 results

Search Page